Diplomat says UN may act as mediator at Astana talks between Damascus and oppositionRussian Politics & Diplomacy January 17, 21:31
Expert believes Brexit to bring UK closer to USWorld January 17, 20:29
Italian Foreign Ministry: It is necessary to assess conditions for returning to G8 formatWorld January 17, 20:04
Russia hopes ECHR will cancel its ruling on Dima Yakovlev Law — diplomatRussian Politics & Diplomacy January 17, 19:35
Preserving Moldova's neutrality impossible without partnership with Russia — presidentWorld January 17, 19:10
OPEC to monitor oil production, export — Saudi Arabian Energy MinisterBusiness & Economy January 17, 18:57
Group of Sukhoi-24M bombers to return from Syria soon — Defense MinistryMilitary & Defense January 17, 18:50
Russian reconciliation center reports over 1,130 Syrian settlements join ceasefireWorld January 17, 18:47
Over 5,000 Syrians get medical aid from Russian doctorsWorld January 17, 18:37
MOSCOW, September 02. /ITAR-TASS/. The Russian government’s foreign investment commission has cleared US company Abbot purchase of Russia’s major pharmaceutical producer Veropharm for $650 million, Director of the Federal Antimonopoly Service Igor Artemyev said Tuesday.
“The first deal, which has been cleared by the commission today, is large US company Abbot buying Veropharm that produces many important medicines for the treatment of oncological diseases, acute leukemia and others,” Artemyev said.
He also said the sum of the deal comprises the cost of Veropharm and its affiliates, while $250 million more will be allocated for the construction of new production sites increasing the production’s localization.
On June 24, Abbott said that it will acquire Veropharm from its largest shareholder Roman Avdeyev for $13.6-17 billion rubles. The purchase price will depend on the stake which Avdeyev’s holding Garden Hills, which currently owns about 81% in Veropharm, can consolidate at the moment when the contract is signed.
Abbot also agreed to repay Veropharm’s debts of 4.7 billion rubles, or $136 million.